Literature DB >> 7796300

Components of a Stat recognition code: evidence for two layers of molecular selectivity.

U Schindler1, P Wu, M Rothe, M Brasseur, S L McKnight.   

Abstract

Latent and activated forms of Stat1 and Stat6 have been expressed and purified, enabling biochemical experiments relating to their functional activities. Stat1 bound to a phosphotyrosine peptide derived from the IFN gamma receptor with a KD of 50 nM, whereas Stat6 bound to an IL-4 receptor peptide with a KD of 300 nM. Stat-receptor peptide interactions were specific and dependent upon tyrosine phosphorylation. Activated forms of Stat1 and Stat6 were used to select their optimal DNA binding sites. Stat1 selected a recognition site having dyad half-sites separated by 3 bp. Stat6 selected a recognition site composed of the same dyad half-sites, yet separated by 4 bp. Chimeric Stat1-Stat6 recombinants were expressed, purified, and assayed for receptor coupling and DNA binding specificity. Such studies led to the identification of polypeptide domains that specify these activities. These observations provide a framework for understanding how different cytokines elicit distinctive patterns of gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796300     DOI: 10.1016/1074-7613(95)90013-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  58 in total

1.  Nuclear export signal located within theDNA-binding domain of the STAT1transcription factor.

Authors:  K M McBride; C McDonald; N C Reich
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

2.  Molecular characterization of the porcine STAT4 and STAT6 genes.

Authors:  Jing Huang; Guojian Ma; Mengjin Zhu; Jianzhi Pan; Wenchang Zhang; Shu-Hong Zhao
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

3.  Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

Authors:  S T Smiley; S N Boyer; M J Heeb; J H Griffin; M J Grusby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.

Authors:  E Soldaini; S John; S Moro; J Bollenbacher; U Schindler; W J Leonard
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNgamma/Stat1 signals.

Authors:  Yu Yang; Jordi C Ochando; Jonathan S Bromberg; Yaozhong Ding
Journal:  Blood       Date:  2007-06-15       Impact factor: 22.113

Review 6.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

7.  The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4.

Authors:  Faruk Sheikh; Harold Dickensheets; Joao Pedras-Vasconcelos; Thirumalai Ramalingam; Laura Helming; Siamon Gordon; Raymond P Donnelly
Journal:  J Innate Immun       Date:  2015-03-07       Impact factor: 7.349

8.  Requirements for interleukin-4-induced gene expression and functional characterization of Stat6.

Authors:  T Mikita; D Campbell; P Wu; K Williamson; U Schindler
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 9.  Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration.

Authors:  Suzan Dziennis; Nabil J Alkayed
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

10.  Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.

Authors:  R Moriggl; V Gouilleux-Gruart; R Jähne; S Berchtold; C Gartmann; X Liu; L Hennighausen; A Sotiropoulos; B Groner; F Gouilleux
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.